This feature is a deep dive into the challenges of defining and treating Difficult-to-Treat Rheumatoid Arthritis (D2T-RA).

A positive association was found between osteoarthritis and overactive bladder (OAB), but rheumatoid arthritis and psoriatic ...

Psoriatic arthritis (PsA) a type of arthritis affecting joints. PsA may also involve enthesitis, a condition that affects ligaments and tendons where they connect to bone. Psoriatic arthritis (PsA ...

Chen TL et al. Risk of major adverse cardiovascular events and venous thromboembolic events between patients with psoriasis or psoriatic arthritis on tumor necrosis factor inhibitors, interleukin 17 ...

While a good quality mattress can’t cure arthritis pain, it may be able to improve your sleep quality — something that’s inextricably linked to quality of life. We’ve put together a list ...

The Arthritis Foundation states that research on CBD for arthritis is promising but inconclusive. While several animal studies show potential, no well-designed trials prove CBD cream benefits ...

Most of the time, psoriasis is the first symptom of psoriatic arthritis. It causes silvery-white skin lesions called plaques, which may appear on your scalp, elbows, knees, and lower back. Eventually, ...

As with other drugs, Tavneos (avacopan) can cause side effects, such as headache and nausea. If you are not able to tolerate side effects of Tavneos, talk with your doctor or pharmacist. Tavneos ...

According to a recent study on patient and clinician perspective on the different aspects of psoriatic arthritis (PsA) care, patients and clinicians agree on core aspects such as joint pain and ...

Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on data from 2 phase 3 trials: BE OPTIMAL and BE COMPLETE. Patient ...

This pilot study investigates distinctive features within the nail-enthesis complex among Psoriatic arthritis (PsA), Psoriasis (PSO), Rheumatoid Arthrit is (RA), and Healthy Control (HC) groups, ...

Psoriatic arthritis (PsA) develops in four stages: the preclinical stage, where those with psoriasis (PsO) are at higher risk but have no symptoms; the subclinical stage, where inflammation is visible ...